These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 17000940

  • 1. Impact of medication therapy discontinuation on mortality after myocardial infarction.
    Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, Krumholz HM, Rumsfeld JS.
    Arch Intern Med; 2006 Sep 25; 166(17):1842-7. PubMed ID: 17000940
    [Abstract] [Full Text] [Related]

  • 2. Association of early follow-up after acute myocardial infarction with higher rates of medication use.
    Daugherty SL, Ho PM, Spertus JA, Jones PG, Bach RG, Krumholz HM, Peterson ED, Rumsfeld JS, Masoudi FA.
    Arch Intern Med; 2008 Mar 10; 168(5):485-91; discussion 492. PubMed ID: 18332293
    [Abstract] [Full Text] [Related]

  • 3. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG.
    Am J Med; 2004 Jul 15; 117(2):73-81. PubMed ID: 15234641
    [Abstract] [Full Text] [Related]

  • 4. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
    Lee JH, Yang DH, Park HS, Cho Y, Jeong MH, Kim YJ, Kim KS, Hur SH, Seong IW, Hong TJ, Cho MC, Kim CJ, Jun JE, Park WH, Chae SC, Korea Acute Myocardial Infarction Registry Investigators.
    Am Heart J; 2010 Jun 15; 159(6):1012-9. PubMed ID: 20569714
    [Abstract] [Full Text] [Related]

  • 5. Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Björck L, Wallentin L, Stenestrand U, Lappas G, Rosengren A.
    Arch Intern Med; 2010 Aug 09; 170(15):1375-81. PubMed ID: 20696964
    [Abstract] [Full Text] [Related]

  • 6. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC, Tu JV, Ko DT, Alter DA.
    CMAJ; 2008 Oct 21; 179(9):901-8. PubMed ID: 18936455
    [Abstract] [Full Text] [Related]

  • 7. Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study.
    Frilling B, Schiele R, Gitt AK, Zahn R, Schneider S, Glunz HG, Gieseler U, Jagodzinski E, Senges J, Maximal Individual Therapy in Acute Myocardial Infarction Study Group.
    Am Heart J; 2004 Aug 21; 148(2):306-11. PubMed ID: 15309001
    [Abstract] [Full Text] [Related]

  • 8. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
    Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC.
    J Am Coll Cardiol; 2008 Apr 01; 51(13):1247-54. PubMed ID: 18371553
    [Abstract] [Full Text] [Related]

  • 9. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
    Wienbergen H, Zeymer U, Gitt AK, Juenger C, Schiele R, Heer T, Towae F, Senges J, MITRA PLUS Study Group.
    Am J Cardiol; 2007 May 01; 99(9):1208-11. PubMed ID: 17478143
    [Abstract] [Full Text] [Related]

  • 10. Implications of the failure to identify high-risk electrocardiogram findings for the quality of care of patients with acute myocardial infarction: results of the Emergency Department Quality in Myocardial Infarction (EDQMI) study.
    Masoudi FA, Magid DJ, Vinson DR, Tricomi AJ, Lyons EE, Crounse L, Ho PM, Peterson PN, Rumsfeld JS, Emergency Department Quality in Myocardial Infarction Study Investigators.
    Circulation; 2006 Oct 10; 114(15):1565-71. PubMed ID: 17015790
    [Abstract] [Full Text] [Related]

  • 11. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A.
    Clin Ther; 2005 Nov 10; 27(11):1806-14. PubMed ID: 16368451
    [Abstract] [Full Text] [Related]

  • 12. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.
    Haddad H, Searles G, Gillis A.
    Can J Cardiol; 2001 Feb 10; 17(2):179-83. PubMed ID: 11223488
    [Abstract] [Full Text] [Related]

  • 13. Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction.
    Winkelmayer WC, Charytan DM, Levin R, Avorn J.
    Am J Kidney Dis; 2006 Feb 10; 47(2):301-8. PubMed ID: 16431259
    [Abstract] [Full Text] [Related]

  • 14. Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach.
    Zeymer U, Jünger C, Zahn R, Bauer T, Bestehorn K, Senges J, Gitt A.
    Curr Med Res Opin; 2011 Aug 10; 27(8):1563-70. PubMed ID: 21682553
    [Abstract] [Full Text] [Related]

  • 15. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction.
    Jackevicius CA, Li P, Tu JV.
    Circulation; 2008 Feb 26; 117(8):1028-36. PubMed ID: 18299512
    [Abstract] [Full Text] [Related]

  • 16. Effect of clopidogrel on 1-year mortality in hospital survivors of acute ST-segment elevation myocardial infarction in clinical practice.
    Zeymer U, Gitt AK, Jünger C, Heer T, Wienbergen H, Koeth O, Bauer T, Mark B, Zahn R, Gottwik M, Senges J, Acute COronary Syndromes (ACOS) registry investigators.
    Eur Heart J; 2006 Nov 26; 27(22):2661-6. PubMed ID: 17043060
    [Abstract] [Full Text] [Related]

  • 17. Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction.
    Spencer FA, Fonarow GC, Frederick PD, Wright RS, Every N, Goldberg RJ, Gore JM, Dong W, Becker RC, French W, National Registry of Myocardial Infarction.
    Arch Intern Med; 2004 Oct 25; 164(19):2162-8. PubMed ID: 15505131
    [Abstract] [Full Text] [Related]

  • 18. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F, Loma-Osorio A, Vila J, López-Bescós L, Cuñat J, Rodríguez E, San José JM, Heras M, Marrugat J, Investigadores del PRIAMHO II.
    Rev Esp Cardiol; 2006 Apr 25; 59(4):313-20. PubMed ID: 16709383
    [Abstract] [Full Text] [Related]

  • 19. Discontinuation of statin therapy following an acute myocardial infarction: a population-based study.
    Daskalopoulou SS, Delaney JA, Filion KB, Brophy JM, Mayo NE, Suissa S.
    Eur Heart J; 2008 Sep 25; 29(17):2083-91. PubMed ID: 18664465
    [Abstract] [Full Text] [Related]

  • 20. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H, Ichimiya S, Kanashiro M, Aoyama T, Ogawa Y, Murakami R, Amano T, Naruse K, Matsubara T, Murohara T.
    Clin Ther; 2006 Nov 25; 28(11):1812-9. PubMed ID: 17213001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.